var data={"name":"Prostate cancer","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Diagnosis","type":"SUBSECTION","items":[{"name":"Clinical presentation and diagnosis of prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-prostate-cancer"},{"name":"Initial staging and evaluation of men with newly diagnosed prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-staging-and-evaluation-of-men-with-newly-diagnosed-prostate-cancer"},{"name":"Interpretation of prostate biopsy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interpretation-of-prostate-biopsy"},{"name":"The role of magnetic resonance imaging in prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-role-of-magnetic-resonance-imaging-in-prostate-cancer"}]},{"name":"General issues","type":"SUBSECTION","items":[{"name":"Active surveillance for men with low-risk, clinically localized prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=active-surveillance-for-men-with-low-risk-clinically-localized-prostate-cancer"},{"name":"Clinical presentation and diagnosis of prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-prostate-cancer"},{"name":"Follow-up surveillance during and after treatment for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=follow-up-surveillance-during-and-after-treatment-for-prostate-cancer"},{"name":"Initial staging and evaluation of men with newly diagnosed prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-staging-and-evaluation-of-men-with-newly-diagnosed-prostate-cancer"},{"name":"Molecular biology of prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-biology-of-prostate-cancer"},{"name":"Molecular prognostic tests for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=molecular-prognostic-tests-for-prostate-cancer"},{"name":"Precancerous lesions of the prostate: Pathology and clinical implications","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=precancerous-lesions-of-the-prostate-pathology-and-clinical-implications"}]},{"name":"Prevention","type":"SUBSECTION","items":[{"name":"Chemoprevention strategies in prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chemoprevention-strategies-in-prostate-cancer"}]},{"name":"Screening","type":"SUBSECTION","items":[{"name":"Genetic risk factors for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=genetic-risk-factors-for-prostate-cancer"},{"name":"Measurement of prostate-specific antigen","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=measurement-of-prostate-specific-antigen"},{"name":"Patient education: Prostate cancer screening (Beyond the Basics)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prostate-cancer-screening-beyond-the-basics"},{"name":"Risk factors for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risk-factors-for-prostate-cancer"},{"name":"Screening for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-prostate-cancer"}]},{"name":"Staging","type":"SUBSECTION","items":[{"name":"Clinical presentation and diagnosis of prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-presentation-and-diagnosis-of-prostate-cancer"},{"name":"Initial staging and evaluation of men with newly diagnosed prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-staging-and-evaluation-of-men-with-newly-diagnosed-prostate-cancer"},{"name":"Interpretation of prostate biopsy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=interpretation-of-prostate-biopsy"},{"name":"Prostate cancer: Risk stratification and choice of initial treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prostate-cancer-risk-stratification-and-choice-of-initial-treatment"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Alternative endocrine therapies for castration-resistant prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=alternative-endocrine-therapies-for-castration-resistant-prostate-cancer"},{"name":"Bone metastases in advanced prostate cancer: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-metastases-in-advanced-prostate-cancer-clinical-manifestations-and-diagnosis"},{"name":"Bone metastases in advanced prostate cancer: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-metastases-in-advanced-prostate-cancer-management"},{"name":"Brachytherapy for localized prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=brachytherapy-for-localized-prostate-cancer"},{"name":"Castration-resistant prostate cancer: Treatments targeting the androgen pathway","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=castration-resistant-prostate-cancer-treatments-targeting-the-androgen-pathway"},{"name":"Chemotherapy in castration-resistant prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=chemotherapy-in-castration-resistant-prostate-cancer"},{"name":"Clinical manifestations, diagnosis, and treatment of radiation proctitis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-radiation-proctitis"},{"name":"Cryotherapy and other ablative techniques for the initial treatment of prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=cryotherapy-and-other-ablative-techniques-for-the-initial-treatment-of-prostate-cancer"},{"name":"External beam radiation therapy for localized prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=external-beam-radiation-therapy-for-localized-prostate-cancer"},{"name":"Follow-up surveillance during and after treatment for prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=follow-up-surveillance-during-and-after-treatment-for-prostate-cancer"},{"name":"Immunotherapy for castration-resistant prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=immunotherapy-for-castration-resistant-prostate-cancer"},{"name":"Initial approach to low- and very low-risk clinically localized prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-approach-to-low-and-very-low-risk-clinically-localized-prostate-cancer"},{"name":"Initial management of regionally localized intermediate-, high-, and very high-risk prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-management-of-regionally-localized-intermediate-high-and-very-high-risk-prostate-cancer"},{"name":"Initial systemic therapy for castration-sensitive prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=initial-systemic-therapy-for-castration-sensitive-prostate-cancer"},{"name":"Investigational approaches for the treatment of advanced prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=investigational-approaches-for-the-treatment-of-advanced-prostate-cancer"},{"name":"Osteoclast inhibitors for patients with bone metastases from breast, prostate, and other solid tumors","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoclast-inhibitors-for-patients-with-bone-metastases-from-breast-prostate-and-other-solid-tumors"},{"name":"Overview of the treatment of castration-resistant prostate cancer (CRPC)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-castration-resistant-prostate-cancer-crpc"},{"name":"Overview of the treatment of disseminated castration-sensitive prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-treatment-of-disseminated-castration-sensitive-prostate-cancer"},{"name":"Patient education: Prostate cancer treatment; stage I to III cancer (Beyond the Basics)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prostate-cancer-treatment-stage-i-to-iii-cancer-beyond-the-basics"},{"name":"Patient education: Treatment for advanced prostate cancer (Beyond the Basics)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-for-advanced-prostate-cancer-beyond-the-basics"},{"name":"Prostate cancer in elderly patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prostate-cancer-in-elderly-patients"},{"name":"Prostate cancer: Pathologic stage T3 disease or positive surgical margins following radical prostatectomy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prostate-cancer-pathologic-stage-t3-disease-or-positive-surgical-margins-following-radical-prostatectomy"},{"name":"Radical prostatectomy for localized prostate cancer","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=radical-prostatectomy-for-localized-prostate-cancer"},{"name":"Rising or persistently elevated serum PSA following radical prostatectomy for prostate cancer: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rising-or-persistently-elevated-serum-psa-following-radical-prostatectomy-for-prostate-cancer-management"},{"name":"Rising serum PSA after radiation therapy for localized prostate cancer: Salvage local therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rising-serum-psa-after-radiation-therapy-for-localized-prostate-cancer-salvage-local-therapy"},{"name":"Rising serum PSA after treatment for localized prostate cancer: Systemic therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rising-serum-psa-after-treatment-for-localized-prostate-cancer-systemic-therapy"},{"name":"Rising serum PSA following local therapy for prostate cancer: Definition, natural history, and risk stratification","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rising-serum-psa-following-local-therapy-for-prostate-cancer-definition-natural-history-and-risk-stratification"},{"name":"Rising serum PSA following local therapy for prostate cancer: Diagnostic evaluation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=rising-serum-psa-following-local-therapy-for-prostate-cancer-diagnostic-evaluation"},{"name":"Side effects of androgen deprivation therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=side-effects-of-androgen-deprivation-therapy"}]}]}